Stock screener

INDV

Conviction 100HealthcareScan · Thu, Jun 25, 2026
INDV$41.29-0.43%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.89M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Indivior Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.indivior.com
Price41.29
Change-0.43%
Gap+0.10%
Rel volume2.39×
Avg volume1.89M
Avg $ vol71.68M
SMA 2037.79
SMA 5036.87
SMA 20032.34
Price vs 50+11.98%
Price vs 200+27.67%
MA stackbullish
50/200 cross
Supertrendup · 36.96
RSI (14)71
MACD hist0.33
MACD cross
Stoch %K / %D85 / 93
ADX (14)22
+DI / −DI33 / 12
RSI divergence
MACD divergence
ATR %+3.31%
ADR %3.62%
52w high41.47
52w low13.69
From 52w high-0.43%
Above 52w low+201.61%
New 52w highYes
SqueezeOff
Bollinger width19.50%
%B0.98
Donchian pos92.21%
Donchian high42.04
Donchian low32.41
AVWAP (52w high)41.16
vs AVWAP high+0.32%
AVWAP (52w low)29.00
vs AVWAP low+42.38%
OBV trendFlat
Chaikin MF (20)0.01
Today vs 20d2.39×
Avg vol (14d)1.89M
Avg vol (20d)1.89M
Avg $ vol (20d)71.68M
Market cap5.03B
RS 3m (vs SPY)+31.79%
RS 6m (vs SPY)+10.04%
RS line new highYes
Trend template8/8
Technical rank84.6
1 week+8.86%
1 month+9.20%
3 months+36.45%
6 months+13.28%
1 year+196.62%
YTD+15.56%
P/E23.97
P/B-34.96
P/S4.06
P/FCF-54.13
EPS1.64
Div yield
ROE-145.83%
ROA17.54%
Debt/Eq-3.38
Current0.86
EV/EBITDA19.65
Gross margin80.23%
Net margin16.95%
Rev growth4.29%
EPS growth2900.00%
Price target51.00
Target upside23.52%
Analyst ratingBuy
Institutional109.65%
Ent. value5.35B
Revenue317M
Net income89M
Gross profit277M
Free cash flow-93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out121.92M
Employees838
ListedWed, Dec 24, 2014
Free float114.59M
Float %91.8%
Short interest12.66M
Days to cover7.7d
Short volume40.3%
Squeeze score62 / 100
Next earningsThu, Jul 30, 2026 (35d)
EPS forecast$0.97 · 1 est
Last EPS vs est$0.96 vs $0.64
Last surprise+50.0% beat
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank84.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance40.51
Support34.11
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INDV

All disclosures →
No recent disclosed trades by Congress in INDV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INDV · 7 buys · 2 sells

InsiderSideShares
Preblick Ryan
Chief Financial Officer · Common Stock · 2026-06-08
Sell36K
Stejbach Mark
Director · Common Stock · 2026-05-13
Grant6.52K
Thompson Juliet
Director · Common Stock · 2026-05-13
Grant6.52K
Kingsley Stuart A
Director · Common Stock · 2026-05-13
Grant6.52K
Humphreys Keith
Director · Common Stock · 2026-05-13
Grant6.52K
Ryan Barbara
Director · Common Stock · 2026-05-13
Grant6.52K
NINIVAGGI DANIEL A
Director · Common Stock · 2026-05-13
Grant6.52K
Wheadon David E.
Director · Common Stock · 2026-05-13
Grant10.43K
Thompson Juliet
Director · Common Stock · 2026-05-12
Other
Thompson Juliet
Director · Common Stock · 2026-05-12
Tax1.12K

SEC filings

EDGAR filings in INDV · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.